
Mirum Pharmaceuticals Set to Report Livmarli Trial Results Monday
Mirum Pharmaceuticals will report clinical trial results for its drug Livmarli on Monday, a binary catalyst that could sharply move the biotech's shares. Positive data may expand the drug's indication...






















